307 related articles for article (PubMed ID: 33650671)
1. Metabolic heterogeneity and immunocompetence of infiltrating immune cells in the breast cancer microenvironment (Review).
Chen H; Sun Y; Yang Z; Yin S; Li Y; Tang M; Zhu J; Zhang F
Oncol Rep; 2021 Mar; 45(3):846-856. PubMed ID: 33650671
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
Nascimento C; Ferreira F
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
[TBL] [Abstract][Full Text] [Related]
3. Improving Breast Cancer Responses to Immunotherapy-a Search for the Achilles Heel of the Tumor Microenvironment.
Jenkins S; Wesolowski R; Gatti-Mays ME
Curr Oncol Rep; 2021 Mar; 23(5):55. PubMed ID: 33755828
[TBL] [Abstract][Full Text] [Related]
4. The Immune Microenvironment in Breast Carcinoma: Predictive and Prognostic Role in the Neoadjuvant Setting.
Badr NM; Berditchevski F; Shaaban AM
Pathobiology; 2020; 87(2):61-74. PubMed ID: 31715606
[TBL] [Abstract][Full Text] [Related]
5. The Tumor Immune Microenvironment in Breast Cancer Progression.
Otterlei Fjørtoft M; Huse K; Rye IH
Acta Oncol; 2024 May; 63():359-367. PubMed ID: 38779867
[TBL] [Abstract][Full Text] [Related]
6. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
[TBL] [Abstract][Full Text] [Related]
7. The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies.
Baxevanis CN; Fortis SP; Perez SA
Semin Cancer Biol; 2021 Jul; 72():76-89. PubMed ID: 31881337
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.
Soongsathitanon J; Jamjuntra P; Sumransub N; Yangngam S; De la Fuente M; Landskron G; Thuwajit P; Hermoso MA; Thuwajit C
J Immunol Res; 2021; 2021():8840066. PubMed ID: 34337083
[TBL] [Abstract][Full Text] [Related]
9. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
[TBL] [Abstract][Full Text] [Related]
10. NK Cell Metabolism and Tumor Microenvironment.
Terrén I; Orrantia A; Vitallé J; Zenarruzabeitia O; Borrego F
Front Immunol; 2019; 10():2278. PubMed ID: 31616440
[TBL] [Abstract][Full Text] [Related]
11. [Research progress on nonspecific immune microenvironment in breast cancer].
Xu Z; Cui Y; Li Y; Guo Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 47(4):426-434. PubMed ID: 30511532
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
13. Role of immune regulatory cells in breast cancer: Foe or friend?
Lan HR; Du WL; Liu Y; Mao CS; Jin KT; Yang X
Int Immunopharmacol; 2021 Jul; 96():107627. PubMed ID: 33862552
[TBL] [Abstract][Full Text] [Related]
14. New insights into the role of the immune microenvironment in breast carcinoma.
de la Cruz-Merino L; Barco-Sánchez A; Henao Carrasco F; Nogales Fernández E; Vallejo Benítez A; Brugal Molina J; Martínez Peinado A; Grueso López A; Ruiz Borrego M; Codes Manuel de Villena M; Sánchez-Margalet V; Nieto-García A; Alba Conejo E; Casares Lagar N; Ibáñez Martínez J
Clin Dev Immunol; 2013; 2013():785317. PubMed ID: 23861693
[TBL] [Abstract][Full Text] [Related]
15. Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology.
Segovia-Mendoza M; Morales-Montor J
Front Immunol; 2019; 10():348. PubMed ID: 30881360
[TBL] [Abstract][Full Text] [Related]
16. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
17. The Immune Landscape in Women Cancers.
Timperi E; Vissio E; Marchiò C; Romano E
Cancer Treat Res; 2020; 180():215-249. PubMed ID: 32215872
[TBL] [Abstract][Full Text] [Related]
18. Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression.
Hanamura T; Kitano S; Kagamu H; Yamashita M; Terao M; Tsuda B; Okamura T; Kumaki N; Hozumi K; Harada N; Iwamoto T; Honda C; Kurozumi S; Niikura N
Sci Rep; 2022 May; 12(1):8098. PubMed ID: 35577913
[TBL] [Abstract][Full Text] [Related]
19. Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures.
Wang T; Li T; Li B; Zhao J; Li Z; Sun M; Li Y; Zhao Y; Zhao S; He W; Guo X; Ge R; Wang L; Ding D; Liu S; Min S; Zhang X
Front Immunol; 2022; 13():805184. PubMed ID: 35154121
[TBL] [Abstract][Full Text] [Related]
20. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
